W.R. Berkley Corp’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

W.R. Berkley Corp’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-63,040	Closed	-$2.93M	–	139
2019 Q4	$2.96M	Buy	+63,040	New	+$2.79M	0.54%	47

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

W.R. Berkley Corp's RARX Position: Q1 2020 in Review

W.R. Berkley Corp sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q1 2020, closing a stake of 63,040 shares — an estimated $2.93M sold.

W.R. Berkley Corp first reported a position in RARX in Q4 2019 and held it in 1 quarter. The position peaked at $2.96M in Q4 2019. 144 funds tracked by Wall St. Rank hold RARX as of Q1 2020.

W.R. Berkley Corp reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
W.R. Berkley Corp sold 63,040 Ra Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $2.93M.
W.R. Berkley Corp first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
W.R. Berkley Corp's Ra Pharmaceuticals, Inc. Common Stock position peaked at $2.96M in Q4 2019.
144 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on W.R. Berkley Corp's 13F filing for Q1 2020, filed 15 May 2020.